N-HYDROXYARYLAMINES

REFERENCES

• Rehn L. Ueber Blasentumoren bei Fuchsinarbeitern. Arch. Clin. Chir. 1895; 50: 588–600
   Google Scholar
• Garner R.C., Martin C.N., Clayson D.B. Carcinogenic Aromatic Amines and Related Compounds. Chemical Carcinogens, C.E. Searle. 2nd Ed., American Chemical Society, Washington, DC 1984; Vol. 1: 175–276
   Google Scholar
• Hueper W.C., Wiley F.H., Wolfe H.D. Experimental Production of Bladder Tumors in Dogs by Administration of Beta-Naphthylamine. J. Ind. Hyg. Toxicol. 1938; 20: 46–84
   Google Scholar
• Miller E.C., Miller J.A., Brown R.R., MacDonald J.C. On the Protective Action of Certain Polycyclic Aromatic Hydrocarbons Against Carcinogenesis by Aminoazo Dyes and 2-Acetylaminofluorene. Cancer Res. 1958; 18: 469–477
   PubMed Web of Science ®Google Scholar
• Weisburger J.H., Weisburger E.K., Morris H.P. Orientation of Biochemical Hydroxylation in Aromatic Compounds. Science 1957; 125: 503
   PubMed Web of Science ®Google Scholar
• Weisburger J.H., Grantham P.H., Vanhorn E., Steigbigel N.H., Rall D.P., Weisburger E.K. Activation and Detoxification of N-2-Fluorenylacetamide in Man. Cancer Res. 1964; 24: 475–479
   PubMed Web of Science ®Google Scholar
• Sugimura T. Mutagens,Carcinogens, and Tumor Promoters in Our Daily Food. Cancer 1982; 49: 1970–1984
   PubMed Web of Science ®Google Scholar
• Wislocki P.G., Miwa G.T., Lu A.Y.H. Reactions Catalyzed by the Cytochrome P-450 system. Enzymatic Basis of Detoxication, W.B. Jakoby. Academic Press, New York 1980; Vol. 1: 135–182
   Google Scholar
• Rosenkranz H.S., Mermelstein R. The Genotoxicity, Metabolism and Carcinogenicity of Nitrated Polycyclic Aromatic Hydrocarbons. J. Environ. Sci. Health 1985; C3: 221–272
   Google Scholar
• Djuric Z., Potter D.W., Heflich R.H., Beland F.A. Aerobic and Anaerobic Reduction of Nitrated Pyrenes In Vitro. Chem.–Biol. Interact. 1986; 59: 309–324
   PubMed Web of Science ®Google Scholar
• Shimada T., Guengerich F.P. Inactivation of 1,3-, 1,6-, and 1,8-Dinitropyrene by Human and Rat Microsomes. Cancer Res. 1990; 50: 2036–2043
   PubMed Web of Science ®Google Scholar
• Rosenkranz H.S. From Adenine to Xanthates: An Aromatic View. Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, C.M. King, L.J. Romano, D. Schuetzle. Elsevier Science, New York 1988; 407–413
   Google Scholar
• Rosenkranz E.J., McCoy E.C., Mermelstein R., Rosenkranz H.S. Evidence for the Existence of Distinct Nitroreductases in Salmonella typhimurium: Roles in Mutagenesis. Carcinogenesis 1982; 3: 121–123
   PubMed Web of Science ®Google Scholar
• Kadlubar F.F., Hammons G.J. The Role of Cytochrome P-450 in the Metabolism of Chemical Carcinogens. Mammalian Cytochromes P-450, F.P. Guengerich. CRC Press, Boca Raton, FL 1987; Vol. 2: 81–130
   Google Scholar
• Frederick C.B., Mays J.B., Ziegler D.M., Guengerich F.P., Kadlubar F.F. Cytochrome P-450 and Flavin-Containing Monooxygenase-Catalyzed Formation of the Carcinogen N-Hydroxy-2-aminofluorene, and Its Covalent Binding to Nuclear DNA. Cancer Res. 1982; 42: 2671–2677
   PubMed Web of Science ®Google Scholar
• Hammons G.J., Guengerich F.P., Weis C.C., Beland F.A., Kadlubar F.F. Metabolic Oxidation of Carcinogenic Arylamines by Rat, Dog, and Human Hepatic Microsomes and by Purified Flavin-Containing and Cytochrome P-450 Monooxygenases. Cancer Res. 1985; 45: 3578–3585
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Zenser T.V., Miller D.W., Kadlubar F.F. Mechanism of Formation and Structural Characterization of DNA Adducts Derived from Peroxidative Activation of Benzidine. Carcinogenesis 1988; 9: 1635–1641
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Miller D.W., Weis C.C., Dooley K.L., Zenser T.V., Beland F.A., Kadlubar F.F. DNA Adducts Formed by Ring-Oxidation of the Carcinogen 2-Naphthylamine with Prostaglandin H Synthase In Vitro and in the Dog Urothelium In Vivo. Carcinogenesis 1985; 6: 1379–1387
   PubMed Web of Science ®Google Scholar
• Seto Y., Guengerich F.P. Partitioning Between N-Dealkylation and N-Oxygenation in the Oxidation of N,N-Dialkylarylamines Catalyzed by Cytochrome P450 2B1. J. Biol. Chem. 1993; 268: 9986–9997
   PubMed Web of Science ®Google Scholar
• Guengerich F.P., Macdonald T.L. Mechanisms of Cytochrome P-450 Catalysis. F.A.S.E.B. J. 1990; 4: 2453–2459
   Google Scholar
• Guengerich F.P., Macdonald T.L. Sequential Electron Transfer Reactions Catalyzed by Cytochrome P-450 Enzymes. Advances in Electron Transfer Chemistry, P.S. Mariano. JAI Press, Greenwich, CT 1993; Vol. 3: 191–241
   Google Scholar
• Humphreys W.G., Kadlubar F.F., Guengerich F.P. Mechanism of C8 Alkylation of Guanyl Residues by Activated Arylamines: Evidence for a Role of Initial Attack at the N7 Atom. Proc. Natl Acad. Sci. USA 1992; 89: 8278–8282
   PubMed Web of Science ®Google Scholar
• Vaz A.D.N., Pernecky S.J., Raner G.M., Coon M.J. Peroxo-iron and Oxenoid-iron Species as Alternative Oxygenating Agents in Cytochrome P450-Catalyzed Reactions: Switching by Threonine-302 to Alanine Mutagenesis of Cytochrome P450 2B4. Proc. Natl Acad. Sci. USA 1996; 93: 4644–4648
   PubMed Web of Science ®Google Scholar
• Guengerich F.P. Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity. Chem. Res. Toxicol. 2001; 14: 611–650
   PubMed Web of Science ®Google Scholar
• Smith M.B., March J. March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure. Wiley-Interscience, New York 2001; 1541
   Google Scholar
• Guengerich F.P., Vaz A.D.N., Raner G.M., Pernecky S.J., Coon M.J. Evidence for a Role of a Perferryl-Oxygen Complex FeO3+, in N-Oxygenation of Amines by Cytochrome P450 Enzymes. Mol. Pharmacol. 1997; 51: 147–151
   PubMed Web of Science ®Google Scholar
• Kadlubar F.F., Unruh L.E., Beland F.A., Straub K.M., Evans F.E. In Vitro Reaction of the Carcinogen N-Hydroxy-2-naphthylamine with DNA at the C-8 and N2 Atoms of Guanine and at the N6 Atom of Adenine. Carcinogenesis 1980; 1: 139–150
   PubMed Web of Science ®Google Scholar
• Beland F.A., Kadlubar F.F. Metabolic Activation and DNA Adducts of Aromatic Amines and Nitroaromatic Hydrocarbons. Handbook of Experimental Pathology. Carcinogenesis and Mutagenesis, C.S. Cooper, P.L. Grover. Springer-Verlag, Heidelberg 1990; Vol. 94/I: 267–325
   Google Scholar
• Guengerich F.P., Mundkowski R.G., Voehler M., Kadlubar F.F. Formation and Reactions of N7-Aminoguanosine and Derivatives. Chem. Res. Toxicol. 1999; 12: 906–916
   PubMed Web of Science ®Google Scholar
• Tada M., Kohda K. Identification of N4-(Guanosin-7-yl)-4-aminoquinoline 1-Oxide and its Possible Role in Guanine C8 Adduction. Nucleic Acids Symp. Ser. 1993; 29: 25–26
   PubMedGoogle Scholar
• Tarpley W.G., Miller J.A., Miller E.C. Rapid Release of Carcinogen-Guanine Adducts from DNA after Reaction with N-Acetoxy-2-acetylaminofluorene or N-Benzoyloxy-N-methyl-4-aminoazobenzene. Carcinogenesis 1982; 3: 81–88
   PubMed Web of Science ®Google Scholar
• Drinkwater N.R., Miller E.C., Miller J.A. Estimation of Apurinic/Apyrimidinic Sites and Phosphotriesters in Deoxyribonucleic Acid Treated with Electrophilic Carcinogens and Mutagens. Biochemistry 1980; 19: 5087–5092
   PubMed Web of Science ®Google Scholar
• Sodum R.S., Nie G., Fiala E.S. 8-Aminoguanine: A Base Modification Produced in Rat Liver Nucleic Acids by the Hepatocarcinogen 2-Nitropropane. Chem. Res. Toxicol. 1993; 6: 269–276
   PubMed Web of Science ®Google Scholar
• Tullis D.L., Dooley K.L., Miller D.W., Baetcke K.P., Kadlubar F.F. Characterization and Properties of the DNA Adducts Formed from N-Methyl-4-aminoazobenzene in Rats During a Carcinogenic Treatment Regimen. Carcinogenesis 1987; 8: 577–583
   PubMed Web of Science ®Google Scholar
• Kaiya T., Ohta M., Kohda K. Electrophilic Amination of Imidazole Moieties of 9-Ethylguanine and 1-Methylbenzimidazole Derivatives and Reactivities of N-Aminated Products. Tetrahedron 1993; 49: 8795–8804
   Web of Science ®Google Scholar
• Kriek E., Westra J.G. Structural Identification of the Pyrimidine Derivatives Formed from N-(Deoxyguanosin-8-yl)-2-aminofluorene in Aqueous Solution at Alkaline pH. Carcinogenesis 1980; 1: 459–468
   PubMed Web of Science ®Google Scholar
• Minchin R.F., Ilett K.F., Teitel C.H., Reeves P.T., Kadlubar F.F. Direct O-Acetylation of N-Hydroxy Arylamines by Acetylsalicyclic Acid to Form Carcinogen-DNA Adducts. Carcinogenesis 1992; 13: 663–667
   PubMed Web of Science ®Google Scholar
• Kohda K., Baba K., Kawazoe Y. Aminations of Guanosine and Deoxyguanosine with Hydroxylamine-O-sulfonic Acid and 2,4-Dinitrophenoxyamine. Dependence on the Reaction Medium. Nucleic Acids Res. Symp. Ser. 1986; 17: 145–148
   PubMedGoogle Scholar
• Kohda K., Baba K., Kawazoe Y. Electrophilic Amination of Guanine Derivatives. Mechanism for Formation of 8-Aminoguanine Derivatives. Tetrahedron 1990; 46: 1531–1540
   Web of Science ®Google Scholar
• Kohda K., Baba K., Kawazoe Y. Synthesis of 7-Aminoguanosine and Its Conversion of 8-Substituted Derivatives. Chem. Pharm. Bull. 1986; 34: 2298–2301
   Web of Science ®Google Scholar
• Scribner J.D., Miller J.A., Miller E.C. Nucleophilic Substitution on Carcinogenic N-Acetoxy-N-arylacetamides. Cancer Res. 1970; 30: 1570–1579
   PubMed Web of Science ®Google Scholar
• Novak M., Kennedy S.A. Selective Trapping of N-Acetyl-N-(4-biphenyl)nitrenium and N-Acetyl-N-(2-fluorenyl)nitrenium Ions by 2′-Deoxyguanosine in Aqueous Solution. J. Am. Chem. Soc. 1995; 117: 574–575
   Web of Science ®Google Scholar
• Kennedy S.A., Novak M., Kolb B.A. Reactions of Ester Derivatives of Carcinogenic N-(4-Biphenyl)hydroxylamine and the Corresponding Hydroxamic Acid with Purine Nucleosides. J. Am. Chem. Soc. 1997; 119: 7654–7664
   Web of Science ®Google Scholar
• McClelland R.A., Ahmad A., Dicks A.P., Licence V.E. Spectroscopic Characterization of the Initial C8 Intermediate in the Reaction of the 2-Fluorenylnitrenium Ion with 2′-Deoxyguanosine. J. Am. Chem. Soc. 1999; 121: 3303–3310
   Web of Science ®Google Scholar
• Shimada T., Iwasaki M., Martin M.V., Guengerich F.P. Human Liver Microsomal Cytochrome P-450 Enzymes Involved in the Bioactivation of Procarcinogens Detected by umu Gene Response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 1989; 49: 3218–3228
   PubMed Web of Science ®Google Scholar
• Butler M.A., Iwasaki M., Guengerich F.P., Kadlubar F.F. Human Cytochrome P-450PA (P-450IA2), the Phenacetin O-Deethylase, Is Primarily Responsible for the Hepatic 3-Demethylation of Caffeine and N-Oxidation of Carcinogenic Arylamines. Proc. Natl Acad. Sci. USA 1989; 86: 7696–7700
   PubMed Web of Science ®Google Scholar
• Turesky R.J., Constable A., Richoz J., Vargu N., Markovic J., Martin M.V., Guengerich F.P. Differences in Activation of Heterocyclic Aromatic Amines by Rat and Human Liver Microsomes and by Rat and Human Cytochromes P450 1A2. Chem. Res. Toxicol. 1998; 11: 925–936
   PubMed Web of Science ®Google Scholar
• Turesky R.J., Parisod V., Huynh-Ba T., Langouet S., Guengerich F.P. Regioselective Differences in C8 and N-Oxidation of 2-Amino-3,8-dimethylimidazo[4.5-f]quinoxaline by Human and Rat Liver Microsomes and Cytochromes P450 1A2. Chem. Res. Toxicol. 2001; 14: 901–911
   PubMed Web of Science ®Google Scholar
• Shimada T., Wunsch R.M., Hanna I.H., Sutter T.R., Guengerich F.P., Gillam E.M.J. Recombinant Human Cytochrome P450 1B1 Expression in Escherichia coli. Arch. Biochem. Biophys. 1998; 357: 111–120
   PubMed Web of Science ®Google Scholar
• Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of Chemically Diverse Procarcinogens by Human Cytochrome P450 1B1. Cancer Res. 1996; 56: 2979–2984
   PubMed Web of Science ®Google Scholar
• Oda Y., Aryal P., Terashita T., Gillam E.M.J., Guengerich F.P., Shimada T. Metabolic Activation of Heterocyclic Amines and Other Procarcinogens in Salmonella typhimurium umu Tester Strains Expressing Human Cytochrome P450 1A1 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and Human NADPH-P450 Reductase and Bacterial O-Acetyltransferase. Mutat. Res. 2001; 492: 81–90
   PubMed Web of Science ®Google Scholar
• Kamataki T., Kitada M., Komori M., Yokoi T., Kitamura R. Human Fetal Liver Cytochrome P-450: Capacity to Form Genotoxic Metabolites. Tohoku J. Exp. Med. 1992; 168: 89–95
   PubMed Web of Science ®Google Scholar
• Nebert D.W., Bigelow S.W., Okey A.B., Yahagi T., Mori Y., Nagao M., Sugimura T. Pyrolysis Products from Amino Acids and Protein: Highest Mutagenicity Requires Cytochrome P1-450. Proc. Natl Acad. Sci. USA 1979; 76: 5929–5933
   PubMed Web of Science ®Google Scholar
• Ames B.N., Kammen H.O., Yamasaki E. Hair Dyes Are Mutagenic: Identification of a Variety of Mutagenic Ingredients. Proc. Natl Acad. Sci. USA 1975; 72: 2423–2427
   PubMed Web of Science ®Google Scholar
• Watanabe M., Nohmi T., Ishidate M., Jr. New Tester Strains of Salmonella typhimurium Highly Sensitive to Mutagenic Nitroarenes. Biochem. Biophys. Res. Commun. 1987; 147: 974–979
   PubMed Web of Science ®Google Scholar
• Josephy P.D., Gruz P., Nohmi T. Recent Advances in the Construction of Bacterial Genotoxicity Assays. Mutat. Res. 1996; 386: 1–23
   Web of Science ®Google Scholar
• Josephy P.D., DeBruin L.S., Lord H.L., Oak J., Evans D.H., Guo Z., Dong M.-S., Guengerich F.P. Bioactivation of Aromatic Amines by Recombinant Human Cytochrome P450 1A2 Expressed in Bacteria: A Substitute for Mammalian Tissue Preparations in Mutagenicity Testing. Cancer Res. 1995; 55: 799–802
   PubMed Web of Science ®Google Scholar
• Parikh A., Gillam E.M.J., Guengerich F.P. Drug Metabolism by Escherichia coli Expressing Human Cytochromes P450. Nat. Biotechnol. 1997; 15: 784–788
   PubMed Web of Science ®Google Scholar
• Josephy P.D., Evans D.H., Parikh A., Guengerich F.P. Metabolic Activation of Aromatic Amine Mutagens by Simultaneous Expression of Human Cytochrome P450 1A2, NADPH-Cytochrome P450 Reductase, and N-Acetyltransferase in Escherichia coli. Chem. Res. Toxicol. 1998; 11: 70–74
   PubMed Web of Science ®Google Scholar
• Kranendonk M., Mesquita P., Laires A., Vermeulen N.P.E., Rueff J. Expression of Human Cytochrome P450 1A2 in Escherichia coli: A System for Biotransformation and Genotoxicity Studies of Chemical Carcinogens. Mutagenesis 1998; 13: 263–269
   PubMed Web of Science ®Google Scholar
• Suzuki A., Kushida H., Iwata H., Watanabe M., Nohmi T., Fujita K., Gonzalez F.J., Kamataki T. Establishment of a Salmonella Tester Strain Highly Sensitive to Mutagenic Heterocyclic Amines. Cancer Res. 1998; 58: 1833–1838
   PubMed Web of Science ®Google Scholar
• Aryal P., Yoshikawa K., Terashita T., Guengerich F.P., Shimada T., Oda Y. Development of a New Genotoxicity Test System with Salmonella typhimurium OY1001/1A2 Expressing Human Cytochrome P450 1A2 and NADPH-Cytochrome P450 Reductase. Mutat. Res. 1999; 442: 113–120
   PubMed Web of Science ®Google Scholar
• Aryal P., Terashita T., Guengerich F.P., Shimada T., Oda Y. Use of Genetically Engineered Salmonella typhimurium OY1002/1A2 Strain Co-expressing Human Cytochrome P450 1A2 and NADPH-Cytochrome P450 Reductase and Bacterial O-Acetyltransferase in SOS/umu Assay. Environ. Mol. Mutagen. 2000; 36: 121–126
   PubMed Web of Science ®Google Scholar
• Nakamura S., Oda Y., Shimada T., Oki I., Sugimoto K. SOS-Inducing Activity of Chemical Carcinogens and Mutagens in Salmonella typhimurium TA1535/pSK1002: Examination with 151 Chemicals. Mutat. Res. 1987; 192: 239–246
   PubMed Web of Science ®Google Scholar
• Shimada T., Oda Y., Yamazaki H., Mimura M., Guengerich F.P. SOS Function Tests for Studies of Chemical Carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009. Methods in Molecular Genetics, K.W. Adolph. Academic Press, Orlando, FL 1994; Vol. 5: 342–355
   Google Scholar
• Parikh A., Josephy P.D., Guengerich F.P. Selection and Characterization of Human Cytochrome P450 1A2 Mutants with Altered Catalytic Properties. Biochemistry 1999; 38: 5283–5289
   PubMed Web of Science ®Google Scholar
• Yun C.-H., Miller G.P., Guengerich F.P. Rate-Determining Steps in Phenacetin Oxidations by Human Cytochrome P450 1A2 and Selected Mutants. Biochemistry 2000; 39: 11319–11329
   PubMed Web of Science ®Google Scholar
• Yun C.-H., Guengerich F.P. Oxidations of p-Alkoxyacylanilides by Human Cytochrome P450 1A2. Biochemistry 2001; 40: 4521–4530
   PubMed Web of Science ®Google Scholar
• Langouët S., Furge L.L., Kerriguy N., Nakamura K., Guillouzo A., Guengerich F.P. Inhibition of Human Cytochrome P450 Enzymes by 1,2-Dithiole-3-thione, Oltipraz and its Derivatives, and Sulforaphane. Chem. Res. Toxicol. 2000; 13: 245–252
   PubMed Web of Science ®Google Scholar
• Chun Y.-J., Kim S., Kim D., Lee S.-K., Guengerich F.P. A New Selective and Potent Inhibitor of Human Cytochrome P450 1B1 and Its Application to Antimutagenesis. Cancer Res. 2001; 61: 8164–8170
   PubMed Web of Science ®Google Scholar